Cargando…

Multi‐component meningococcal serogroup B (MenB)‐4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency

Vaccination against meningococcal serogroup B is recommended for patients with a complement deficiency; however, although immunogenicity in this patient group has been shown, efficacy has not yet been established. In this study, we collected serum from children with a complement deficiency in the al...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Broek, B., van Els, C. A. C. M., Kuipers, B., van Aerde, K., Henriet, S. S., de Groot, R., de Jonge, M. I., Langereis, J. D., van der Flier, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857189/ https://www.ncbi.nlm.nih.gov/pubmed/31487400 http://dx.doi.org/10.1111/cei.13368

Ejemplares similares

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
por: Patton, Monica E., et al.
Publicado: (2017)

01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults
por: Coyne-Beasley, Tamera, et al.
Publicado: (2021)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement
por: Hogea, Cosmina, et al.
Publicado: (2015)

Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States
por: Rajam, Gowrisankar, et al.
Publicado: (2017)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
por: Sereikaitė, Emilija, et al.
Publicado: (2023)

Complement factor D haplodeficiency is associated with a reduced complement activation speed and diminished bacterial killing
por: Langereis, Jeroen D, et al.
Publicado: (2021)

UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
por: Jackson, Cath, et al.
Publicado: (2017)

Erratum for Rajam et al., “Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States”
por: Rajam, Gowrisankar, et al.
Publicado: (2019)

Routine vaccination against MenB: Considerations for implementation
por: Kaaijk, Patricia, et al.
Publicado: (2014)

Nod1 Signaling Overcomes Resistance of S. pneumoniae to Opsonophagocytic Killing
por: Lysenko, Elena S, et al.
Publicado: (2007)

Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
por: Breton, Marie-Claude, et al.
Publicado: (2020)

A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood
por: van der Maten, Erika, et al.
Publicado: (2017)

Toward an Improved Meningococcal Serogroup B Assay
por: Poolman, Jan
Publicado: (2018)

Recent Progress in the Prevention of Serogroup B Meningococcal Disease
por: Feavers, Ian M., et al.
Publicado: (2017)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
por: Racloz, Vanessa N, et al.
Publicado: (2010)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2018)

An Unexpected Fever Post Serogroup B Meningococcal Sepsis
por: Donà, Daniele, et al.
Publicado: (2016)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
por: Donald, Robert G. K., et al.
Publicado: (2016)

Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015)
por: Tryfinopoulou, Kyriaki, et al.
Publicado: (2016)

Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
por: Tzanakaki, Georgina, et al.
Publicado: (2014)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation
por: Langereis, Jeroen D., et al.
Publicado: (2018)

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2020)

Meningococcal serogroup B disease in Turkey: A guess or reality?
por: Bakir, Mustafa
Publicado: (2014)

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
por: Folaranmi, Temitope, et al.
Publicado: (2015)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010
por: Dang, Vica, et al.
Publicado: (2012)

The Long Road to an Effective Vaccine for Meningococcus Group B (MenB)
por: Shea, Michael W.
Publicado: (2013)

Are physicians obligated to tell parents about the meningococcal serogroup B vaccine?
por: Robinson, Dr Joan L
Publicado: (2015)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
por: Srivastava, Amit, et al.
Publicado: (2020)

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019)

US College Students Are at Increased Risk for Serogroup B Meningococcal Disease
por: Marshall, Gary S, et al.
Publicado: (2019)

Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against Streptococcus pyogenes
por: Salehi, Sanaz, et al.
Publicado: (2018)

Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine
por: Green, Luke R., et al.
Publicado: (2018)

2722. Effects of Sex, Age, and Race on Immunogenicity of MenB-FHbp, a Bivalent Meningococcal B Vaccine: A Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2019)

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
por: Martinelli, Domenico, et al.
Publicado: (2015)

Phase variable acetylation of lipooligosaccharide modifies antibody production and opsonophagocytic killing of non-typeable Haemophilus influenzae
por: Wills, Brandon M., et al.
Publicado: (2023)

Invasive Meningococcal Disease and Meningococcal Serogroup B Vaccination in Adults and Their Offspring: Knowledge, Attitudes, and Practices in Italy (2019)
por: Riccò, Matteo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qjaipaeoib2gqeemvr2phssav4